Prostate Cancer - Results from #22220

Prostate-specific antigen-based prostate cancer screening: Reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer - Abstract September 24, 2013

Benign mimickers of the prostate cancer. Diagnostic challenges - Abstract September 24, 2013

Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes - Abstract September 24, 2013

Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer - Abstract September 23, 2013

Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancer - Abstract September 23, 2013

Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes - Abstract September 23, 2013

Progression of bone metastases in patients with prostate cancer - Automated detection of new lesions and calculation of bone scan index - Abstract September 23, 2013

Novel preclinical models and biomarkers for prostate cancer - Abstract September 23, 2013

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy - Abstract September 23, 2013

Gleason grade progression is uncommon - Abstract September 23, 2013

Treatment of hemorrhagic radiation-induced proctopathy with a 4% formalin application under perianal anesthetic infiltration - Abstract September 23, 2013

Navigating veterans with an abnormal prostate cancer screening test: A quasi-experimental study - Abstract September 23, 2013

Potential of PET/MRI for diagnosis of prostate cancer - Abstract September 23, 2013

Use of hydrogel as spacer in Denovier's space : Optimization of IMRT radiotherapy of localized prostate cancer - Abstract September 20, 2013

Rationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancer - Abstract September 20, 2013

Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials - Abstract September 20, 2013

Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer - Abstract September 20, 2013

Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey - Abstract September 20, 2013

Neoadjuvant hormonal therapy versus surgery alone for radical prostatectomy in high-risk prostate cancer patients - Abstract September 20, 2013

How accurate is our clinical prediction of "minimal prostate cancer"? - Abstract September 20, 2013

Page 1112 of 1436